VSEE HEALTH, INC.
VSEENasdaqHealthcare · Services-Health Services · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
| Revenue | $14.6M | $1.6M | $1.6M | — | — |
| Operating income | −$9.6M | $104,060 | −$715,855 | −$3.6M | −$282,671 |
| Net income | −$14.7M | $62,770 | −$529,962 | −$3.2M | −$280,701 |
| Total assets | $22.4M | $78.6M | $805,791 | $7.6M | $117.9M |
| Total liabilities | $17.0M | $5.6M | $3.9M | $7.7M | $4.6M |
| Equity | $5.5M | −$4.2M | −$12.3M | −$7.4M | −$3.3M |
| EPS (diluted) | $-0.73 | $0.01 | $-0.05 | $-0.25 | $-0.07 |
| Shares out. | 16.4M | 3.6M | 4.2M | 4.2M | 4.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −65.6%
- Net margin
- −100.6%
- Return on equity
- −269.8%
- Return on assets
- −65.6%
- Return on capital (ROCE)
- −155.4%
- Liabilities / assets
- 75.7%
- Debt / equity
- 3.11×
- Book value / share
- $0.33
- Revenue growth (YoY)
- 801.8%
- Net income growth (YoY)
- −23539.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -16.83distress
- Accruals / assets
- −50.3%clean
- Beneish M-Score
- -2.69normal
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2024
- NT 10-Kmissed a reporting deadline ↗Mar 29, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2023
- NT 10-Qmissed a reporting deadline ↗Aug 11, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Armistice Capital, LlcPassive (13G)May 15, 2026
- Alta Partners LlcPassive (13G)Feb 23, 2026
- Dominion Capital LlcPassive (13G)Feb 3, 2026
- Sands Lawrence M.Activist (13D)Dec 4, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 844,732 | 1.4 | +78.9% |
| Apr 30, 2026 | 472,222 | 1.0 | -39.7% |
| Apr 15, 2026 | 783,682 | 1.0 | -22.2% |
| Mar 31, 2026 | 1.0M | 2.8 | -28.1% |
| Mar 13, 2026 | 1.4M | 1.7 | +3.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMar 3, 2026
- Entered a material agreementFeb 19, 2026
- Shareholder voteJan 2, 2026
- Amended charter or bylawsDec 18, 2025
- Regulation FD disclosure · Other material eventDec 12, 2025
- Amended charter or bylawsDec 11, 2025
- Other material eventNov 28, 2025
- Entered a material agreement · Unregistered equity saleNov 26, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 424B3FORM 424B3May 29, 2026
- 10-QFORM 10-QMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- 424B3FORM 424B3Apr 2, 2026
- POS EXFORM POS EXApr 2, 2026
- 10-KFORM 10-KMar 31, 2026
- 4Mar 24, 2026
- 4Mar 24, 2026
- 4Mar 6, 2026
- 4Mar 6, 2026
- 4Mar 5, 2026
- 4Mar 5, 2026
- 4Mar 5, 2026
- 424B3FORM 424B3Mar 5, 2026
- 8-KFORM 8-KMar 3, 2026